Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND). Sponsor: University of South Florida; ClinicalTrials.gov identifier: NCT02179333, First received: June 27, 2014
Subjects with Ataxia, Patients with a diagnosis of ataxia (Friedreich's ataxia or Spinocerebellar ataxia type 1-30) aged 18-80 years old will be recruited for the study.
Wednesday, July 2, 2014
Biomarkers for Mitochondrial Diseases Emerging
Biomarkers for Mitochondrial Diseases Emergin, CHOP, Friedreich’s Ataxia Center of Excellence, by Research Communications, Jul 01 2014
Nuevas aproximaciones terapéticas para el tratamiento de la Ataxia de Friedreich: HBSP y BDNF
Nuevas aproximaciones terapéticas para el tratamiento de la Ataxia de Friedreich: HBSP y BDNF; Autor (es): Katsu Jiménez, Yurika María; Director (es): Díaz Nido, Javier (dir.) Tesis doctoral inédita, leída en Universidad Autónoma de Madrid, Facultad de Ciencias, Departamento de Biología Molecular. Fecha de lectura: 15/07/2013
FULL TEXT PDF
FULL TEXT PDF
Subscribe to:
Posts (Atom)
